Brucella: diagnosis, epidemiology, treatment (7) HIV/AIDS drug development and treatment (6) HIV Research and Treatment (5) Tryptophan and brain disorders (4) Long-Term Effects of COVID-19 (4)

Affiliations

Office of Infectious Diseases

US 2022 - 2022

Regional Center for Prevention and Control of AIDS and Infectious Diseases

RU 2014 - 2014

Saratov State Medical University

RU 2025 - 2002

Saratov Research Center

RU 2013 - 2013

External Profiles

OpenAlex Profile Search Semantic Scholar ORCID Profile Google Scholar

Share Profile

Back to Researchers

А A Shuldyakov

Publication & Citation Trends

Publications

Safety and efficacy of doravirine as first-line therapy in adults with HIV-1: week 192 results from the open-label extensions of the DRIVE-FORWARD and DRIVE-AHEAD phase 3 trials PDF

Mental Health of Medical Workers During the COVID-19 Pandemic in Russia: Results of a Cross-Sectional Study PDF

Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 48-week results of a randomised, double-blind, phase 3, non-inferiority trial

Dolutegravir versus raltegravir in antiretroviral-experienced, integrase-inhibitor-naive adults with HIV: week 48 results from the randomised, double-blind, non-inferiority SAILING study PDF

Research Topics

Affiliations

External Profiles

Share Profile

Journal Details

Join JournalsHub

Welcome Back